Jean Bennett

Insider Reports History

Entity
Individual
Location
C/O Regenxbio Inc., 9804 Medical Center Drive, Rockville, MD
Signature
/s/ Amy Rabourn, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jean Bennett:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Director Common Stock 11.3K $178K $15.81 May 31, 2024 Direct
Ocuphire Pharma, Inc. Director Common Stock 100K $177K $1.77 Oct 22, 2024 Direct
Ocuphire Pharma, Inc. Director Stock Option (right to buy) 173K Oct 22, 2024 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24.5K May 31, 2024 Direct

Insider Reports Filed by Jean Bennett

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRD Opus Genetics, Inc. Oct 22, 2024 2 $0 4 Oct 24, 2024 Director
IRD Opus Genetics, Inc. Oct 22, 2024 0 $0 3 Oct 24, 2024 Director
RGNX REGENXBIO Inc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
RGNX REGENXBIO Inc. Jun 2, 2023 2 $0 4 Jun 6, 2023 Director
RGNX REGENXBIO Inc. Jun 3, 2022 2 $0 4 Jun 7, 2022 Director
RGNX REGENXBIO Inc. Sep 3, 2021 1 $0 4 Sep 8, 2021 Director
RGNX REGENXBIO Inc. Sep 3, 2021 0 $0 3 Sep 8, 2021 Director